BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer

Reuters

Yesterday

Apimeds Pharmaceuticals US Inc APUS.A:

APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICER
APIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICER
APIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENT

Source text: [ID:n0001213900-26-034786]

Further company coverage: APUS.A

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2622990218"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622990218\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622990218?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 04:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622990218","market":"nz","top_or_hot":-1,"title":"BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer</title></head><body><p>Apimeds Pharmaceuticals US Inc <span>APUS.A</span>:</p><ul><li><p>APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICER</p></li><li><p>APIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICER</p></li><li><p>APIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENT</p></li></ul><p>Source text: [ID:n0001213900-26-034786]</p><p>Further company coverage: <span>APUS.A</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 04:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer</title></head><body><p>Apimeds Pharmaceuticals US Inc <span>APUS.A</span>:</p><ul><li><p>APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICER</p></li><li><p>APIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICER</p></li><li><p>APIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENT</p></li></ul><p>Source text: [ID:n0001213900-26-034786]</p><p>Further company coverage: <span>APUS.A</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APUS","symbol_name":"Apimeds Pharmaceutical  U.S, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E156:1","article_id":"2622990218","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622990218","pubTimestamp":1774558375,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive OfficerApimeds Pharmaceuticals US Inc APUS.A:APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICERAPIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICERAPIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENTSource text: [ID:n0001213900-26-034786]Further company coverage: APUS.A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APUS":"Apimeds Pharmaceutical  U.S, Inc.","BK4139":"生物科技"},"translate_title":"简介-Apimeds Pharmaceuticals Us Inc Vin Menon继续担任公司首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APUS":0.9},"content_text":"BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive OfficerApimeds Pharmaceuticals US Inc APUS.A:APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICERAPIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICERAPIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENTSource text: [ID:n0001213900-26-034786]Further company coverage: APUS.A","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}